These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 23346806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A review of meibography.
    Pult H, Nichols JJ.
    Optom Vis Sci; 2012 May; 89(5):E760-9. PubMed ID: 22488268
    [Abstract] [Full Text] [Related]

  • 3. Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms.
    Golebiowski B, Chim K, So J, Jalbert I.
    Optom Vis Sci; 2012 Oct; 89(10):1443-9. PubMed ID: 22922778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea.
    Palamar M, Degirmenci C, Ertam I, Yagci A.
    Cornea; 2015 May; 34(5):497-9. PubMed ID: 25826323
    [Abstract] [Full Text] [Related]

  • 6. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore.
    Tong L, Chaurasia SS, Mehta JS, Beuerman RW.
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3449-54. PubMed ID: 20181848
    [Abstract] [Full Text] [Related]

  • 7. Eyelid disorders: the meibomian gland, blepharitis, and contact lenses.
    McCulley JP, Shine WE.
    Eye Contact Lens; 2003 Jan; 29(1 Suppl):S93-5; discussion S115-8, S192-4. PubMed ID: 12772741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nonobvious obstructive meibomian gland dysfunction.
    Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ.
    Cornea; 2010 Dec; 29(12):1333-45. PubMed ID: 20847669
    [Abstract] [Full Text] [Related]

  • 10. Morphological and Functional Evaluation of Meibomian Gland Dysfunction in Rosacea Patients.
    Machalińska A, Zakrzewska A, Markowska A, Safranow K, Wiszniewska B, Parafiniuk M, Machaliński B.
    Curr Eye Res; 2016 Aug; 41(8):1029-1034. PubMed ID: 26644191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improving awareness, identification, and management of meibomian gland dysfunction.
    Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD.
    Ophthalmology; 2012 Oct; 119(10 Suppl):S1-12. PubMed ID: 23034341
    [Abstract] [Full Text] [Related]

  • 14. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).
    Cuevas M, González-García MJ, Castellanos E, Quispaya R, Parra Pde L, Fernández I, Calonge M.
    Curr Eye Res; 2012 Oct; 37(10):855-63. PubMed ID: 22632103
    [Abstract] [Full Text] [Related]

  • 15. Functional Morphology of the Lipid Layer of the Tear Film.
    Arita R, Fukuoka S, Morishige N.
    Cornea; 2017 Nov; 36 Suppl 1():S60-S66. PubMed ID: 28957980
    [Abstract] [Full Text] [Related]

  • 16. [Influence of cataract surgery on Meibomian gland dysfunction (French translation of the article)].
    El Ameen A, Majzoub S, Vandermeer G, Pisella PJ.
    J Fr Ophtalmol; 2018 Jun; 41(6):526-535. PubMed ID: 29887409
    [Abstract] [Full Text] [Related]

  • 17. Influence of cataract surgery on Meibomian gland dysfunction.
    El Ameen A, Majzoub S, Vandermeer G, Pisella PJ.
    J Fr Ophtalmol; 2018 May; 41(5):e173-e180. PubMed ID: 29778280
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery.
    Han KE, Yoon SC, Ahn JM, Nam SM, Stulting RD, Kim EK, Seo KY.
    Am J Ophthalmol; 2014 Jun; 157(6):1144-1150.e1. PubMed ID: 24561172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.